Does Viagra Cause Cancer? | A mission for truth. Part 1

Viagra (Sildenafil) and Other PDE5 Inhibitors (Cialis, Revatio, Levitra) Linked to Tremendous Growth in Men’s Melanoma Rates

2014/10/07

Melanoma mole with uneven color and irregular border.

Melanoma mole with uneven color and irregular border.

Harvard medical professionals recently released a study on over 15,000 men around the United States linking a whopping 84% increase in men’s risk of melanoma when they used Viagra in the past.
http://www.viagralaw.com/resources/jama-sildinafil-melanoma-study.pdf

An analysis on Caucasians in the United States shows that the number of men with melanoma, relative to women, has increased 107% since 1998 when Viagra was first introduced to the American market by Pfizer.
http://www.viagramelanomaattorney.com/uv-sunburn-risk-vs-erectile-dysfunction-drugs/

Here are the questions we intend to get answers to.

What have the melanoma rates done in other races that have used Viagra, Cialis, Levitra or other PDE5 inhibitors? The following will be the information we seek.

African American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Asian American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Native American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Mixed Race American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

To begin our search for the information we begin with the National Cancer Institute LiveHelp chat line at cancer.gov

The following is the chat record. In part two of our mission for truth, we will begin emailing medical professionals, both public and private, to get our answers.

NCI Agent: Please wait. An agent is connecting.

NCI Agent: Thank you for contacting the National Cancer Institute (NCI). How can I help you today?
You: I am studying the link between Viagra/ Cialis/ Levitra/ Revatio and Melanoma rates. I can NOT get any information for any race other than Caucasian since 1998. Please help me find info on other races melanoma rates since 1998. Here is what I found for Caucasians. http://www.viagramelanomaattorney.com/uv-sunburn-risk-vs-erectile-dysfunction-drugs/

NCI Agent: Thanks for asking. Please wait while I see if I can help you locate some resources for the melanoma rate by race.
You: THANK YOU SO MUCH!!!

NCI Agent:
SEER (Surveillance, Epidemiology and End Results Program)
National Cancer Institute
E-mail: seerweb@imsweb.com*
Website: http://www.seer.cancer.gov

The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) tracks cancer incidence and survival using data from geographically defined, population-based, central cancer registries in the United States. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data.

Additional Resources:
Cancer Statistics Review, 1975-2011: http://seer.cancer.gov/csr/1975_2011/
Fast Stats Tool: http://seer.cancer.gov/faststats/
Cancer Stat Fact Sheets: http://seer.cancer.gov/statfacts/

Perhaps the Cancer Query System: Cancer Prevalence Database would be the most helpful.

http://surveillance.cancer.gov/prevalence/canques.html

Is this the type of information you need?

NCI Agent: Additional resources to aid in your research may include these resources:

PubMed®
National Center for Biotechnology Information, National Library of Medicine
Toll Free: 1-888-346-3656
E-mail: custserv@nlm.nih.gov (PubMed Help Desk)
Website: http://www.ncbi.nlm.nih.gov/pubmed

PubMed provides a free search tool to help people find journal articles of interest in the health and medical sciences. PubMed includes journal article citations in the health and medical sciences dating back to the 1950s from MEDLINE, the National Library of Medicine’s (NLM’s) database of citations and abstracts in health and medical science. Users may have to register, or there may be a fee or subscription required to access the full text.

Also DailyMed may have any know adverse effects for the drugs you are researching.

http://dailymed.nlm.nih.gov/dailymed/index.cfm

Did you have any additional questions?

NCI Agent: I’ll remain connected for a couple of minutes in case you have additional questions. If I haven’t heard back from you I’ll go ahead and disconnect, but please check back with us if you have any additional questions.
You: I have been through the SEER database… They know they do not have what I am looking for. What was the melanoma incidence in AA males in 1998? What is it now?

NCI Agent: The fast stats sheet for melanoma does not break it down by year. Those are the only resources that I am aware of that might aid in your research.
You: That is ridiculous. When was the data obtained? How? What does a tax payer pay for?

NCI Agent: I am sorry to hear that you have communicated with SEER already and it appears that they do not have the statistic you are looking for. If you need additional help you can direct your questions to our Public Inquiries Office.

National Cancer Institute Public Inquiries Office
Cancer Information Service
Phone: 301-435-3848
Email: cancergovstaff@mail.nih.gov

Address:
BG 9609 MSC 9760
9609 Medical Center Drive
Bethesda, MD 20892-9760

The National Cancer Institute’s (NCI’s) Public Inquiries Office responds to inquiries about NCI programs, activities, and initiatives that are beyond the scope of general cancer inquiries. Common examples of public inquiries are (but not limited to) from lawyers seeking information for lawsuits, insurance companies concerning reimbursement, or physicians wishing to speak to an “NCI expert.” Public Inquiries staff also respond to inquiries that are seeking an official NCI opinion or statement on a particular subject.

NCI Agent: I’ll remain connected for a couple of minutes in case you have additional questions. If I haven’t heard back from you I’ll go ahead and disconnect, but please check back with us if you have any additional questions.
You: Please complete the melanoma incidence rate chart below. The chart is being used to compare melanoma incidence among OR since the introduction of PDE5 inhibitors used to ED.

African American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Asian American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Native American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

Mixed Race American Males Melanoma Incidence Rate
1997-1998 = ? = ____
2013-2014 = ? = ____

NCI Agent: I understand you are frustrated. This is beyond the scope of what I can help you with. This information would be good to include when you send the email to our Public Inquiries office.

National Cancer Institute Public Inquiries Office
Cancer Information Service

Email: cancergovstaff@mail.nih.gov

NCI Agent has disconnected.

Comments are closed.